Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 216 Stomach Neoplasms 166 Rectal Neoplasms 146 Pancreatic Neoplasms 81 Colonic Neoplasms 77 Neoplasm Metastasis 67 Esophageal Neoplasms 55 Neoplasms 31 Adenocarcinoma Of Esophagus 29 Cholangiocarcinoma 28 Carcinoma, Hepatocellular 26 Adenocarcinoma 26 Biliary Tract Neoplasms 23 Lymphoma, Large B-Cell, Diffuse 19 Recurrence 17 Carcinoma, Non-Small-Cell Lung 16 Gallbladder Neoplasms 14 Breast Neoplasms 14 Head and Neck Neoplasms 11 Locally Advanced Rectal Cancer 10 Liver Neoplasms 10 Gastrointestinal Neoplasms 10 Esophageal Squamous Cell Carcinoma 9 Peritoneal Neoplasms 8 Ovarian Neoplasms 8 Colorectal Cancer Metastatic 7 Bile Duct Neoplasms 6 Urinary Bladder Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Extranodal NK-T-Cell 5

Interventions

irinotecan sucrosofate 1 Oxaliplatin 1 Fluorouracil 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoadjuvant Chemotherapy × Oxaliplatin × Clear all

NCT06172036 2023-12-15

CAPT-02

Zhejiang University

Phase 2 Not yet recruiting

Gastrointestinal

Neoadjuvant Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡